Genomenon, Inc.
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-07-307/30/26 | New | $6,025,002 | $6,025,002 | Equity Only | 06b | SEC linkSEC |
| 2024-05-165/16/24 | New | $5,461,759 | $5,461,759 | Equity Only | 06b | SEC linkSEC |
| 2022-03-103/10/22 | New | $19,999,994 | $19,999,994 | Equity Only | 06b | SEC linkSEC |
| 2020-05-215/21/20 | New | $2,885,877 | $2,885,877 | Debt Only | 06b | SEC linkSEC |
| 2015-08-148/14/15 | New | $446,003 | $446,003 | Equity Only | 06b | SEC linkSEC |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Patricia Glaza | Director |
| Sam Globus | Executive |
| David Gregorka | Director |
| Brian Groark | Executive |
| Michael Gross | Director |
| Sean Kearney | Executive |
| Mark Kiel | Director, Executive |
| Michael Klein | Director, Executive |
| Charles Moret | Director |
| Eli Salembier | Director, Executive |
| Steve Schwartz | Executive |
| Sonya Sepahban | Director |
Industry: Biotechnology (See others in industry)
Address:
206 E. Huron Street Suite 114
Ann Arbor, MI, 48104
Phone: 734-794-3075
Ann Arbor, MI, 48104
Phone: 734-794-3075